Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2010
08/18/2010CN101804191A Stomach-calming foaming paste used for treating chronic atrophic gastritis and preparation method thereof
08/18/2010CN101804186A Medicine composition for treating infantile diarrhea and preparation method thereof
08/18/2010CN101804174A Traditional Chinese medicine preparation for treating sicca syndrome
08/18/2010CN101804173A Traditional Chinese medicine composition for treating dyspepsia and preparation method thereof
08/18/2010CN101804172A Traditional Chinese medicine composition for treating anorexia and preparation method thereof
08/18/2010CN101804155A Medicine used for treating qi and blood deficiency caused by radiotherapy and chemotherapy of tumor and postoperative body weakness
08/18/2010CN101804154A Health care wind prepared from campanumaea pilosula, barbary wolfberry fruit and rhizoma polygonatum
08/18/2010CN101804140A Oral medicine for preventing and curing canine enteric bacterial disease
08/18/2010CN101804130A Traditional Chinese medicine ointment for treating hepatitis B and preparation technique thereof
08/18/2010CN101804128A Medicine composition, preparation method thereof and use thereof in preparing medicine for curing inflammatory enteropathy
08/18/2010CN101804126A Application of traditional Chinese medicine composition in treating qi-blood deficiency and spleen-kidney deficiency and preparation method thereof
08/18/2010CN101804125A Longan health wine
08/18/2010CN101804120A Traditional Chinese medicine composition for treating toothache
08/18/2010CN101804107A Chinese traditional medicine composition for treating stomatitis
08/18/2010CN101804104A Medicine for treating chronic pancreatitis
08/18/2010CN101804102A Traditional Chinese medicine compound for nonalcoholic steatohepatitis
08/18/2010CN101804101A Medicine for treating pseudotumor of chronic pancreatitis
08/18/2010CN101804085A Brucea javanica oil and pharmaceutical composition containing the same and preparation method thereof
08/18/2010CN101804083A Application of pollen pini and extract thereof in treating inflammatory bowel disease and method for preparing extract
08/18/2010CN101804082A Method for identifying cordyceps sinensis powder through microscopic dyeing
08/18/2010CN101804079A Compound Chinese gall ulcer pellicle and preparation method thereof
08/18/2010CN101804074A Traditional Chinese medicine for treating esophagus cancer
08/18/2010CN101804072A Calculus bovis factitius superfine powder and preparation method
08/18/2010CN101804068A Polyethylene glycol-electrolyte oral solution
08/18/2010CN101804047A Antimicrobial and radioprotective compounds
08/18/2010CN101804036A 多潘立酮口腔崩解片及其制备方法 Domperidone orally disintegrating tablets and its preparation method
08/18/2010CN101804035A Lansoprazole preparation for injection and preparation method thereof
08/18/2010CN101804034A Rabeprazole sodium powder injection and preparation method thereof
08/18/2010CN101804027A Granisetron hydrochloride nasal spray and preparation method thereof
08/18/2010CN101804026A Preparation of interferon fat emulsion for injection
08/18/2010CN101803799A Gypenoside-contained cigarette and manufacture method thereof
08/18/2010CN101548957B Sub-micro emulsion frozen preparation of pantoprazole sodium prepared by using multiple emulsion method
08/18/2010CN101407792B Preparation of pit viper bioactivity enzyme
08/18/2010CN101361870B Traditional Chinese medicine combination for preventing infection after mouth operation
08/18/2010CN101284011B Oleanolic acid orally disintegrating tablet and preparation method thereof
08/18/2010CN101172975B Method of preparing five-alkaloid composition of corydalis saxicola bunting
08/18/2010CN101147582B Secretion promoting cake and making technology thereof
08/18/2010CN101077403B Plaster for treating retention of food and dysmenorrhea
08/18/2010CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/17/2010US7777069 Prodrugs of carbamate inhibitors of IMPDH
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7776918 Remedy for viral disease
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776885 Benzimidazolone compounds having 5-HT4 receptor agonistic activity
08/17/2010US7776879 anticholinergic agents such as Butylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester, having a high affinity for muscarinic M3 receptors, useful for treating respiratory system, urogenital, gastrointestinal and cardiovascular disorders
08/17/2010US7776854 1,3-benzothiazol-2-yl(2-{[4-(morpholin-4-ylmethyl)benzyl]oxy}pyrimidin-4-yl)-acetonitrile; (or benzimidazole or benzoxazole 2-acetonitrile derivatives); systemic sclerosis, CREST, sine scleroderma, cirrhosis, heart failure; inhibitors of JNK (c-Jun N-terminal Kinases)
08/17/2010US7776853 Dietetics therapy; lipase inhibitor
08/17/2010US7776839 Pharmaceutical compositions including alginates and methods of preparing and using same
08/17/2010US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin
08/17/2010US7776820 Methods for decreasing risk of complications of prematurity using IGF-I and its analogs
08/17/2010US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
08/17/2010US7776325 Bactericide against Streptococcus mutans and Streptococcus sobrinus
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2584968C Drug and food or drink for improving pancreatic functions
08/17/2010CA2545092C Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
08/17/2010CA2527203C Casr antagonist
08/17/2010CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/17/2010CA2455296C 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors
08/17/2010CA2431974C Urea and urethane derivatives as integrin inhibitors
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2407208C Process for producing optically active sulfoxide derivative
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/17/2010CA2318008C Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound
08/12/2010WO2010091068A2 Treatment of non-oral biological tissue with chlorine dioxide
08/12/2010WO2010090723A2 Methods of inhibiting fibrogenesis and treating fibrotic disease
08/12/2010WO2010090612A1 Stable, taste and odor masked pharmaceutical compositions comprising acetylcystein and vitamin c
08/12/2010WO2010090441A2 Pharmaceutical composition for the prevention and treatment of irritable bowel syndrome
08/12/2010WO2010090040A1 Monoclonal antibodies that recognize cholangiocarcinoma-specific sugar chain epitopes
08/12/2010WO2010089510A2 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
08/12/2010WO2010088786A1 Herbal composition having cox-2 and immune activities and preparation method thereof
08/12/2010WO2010032154A4 Gangliosides from the avian nervous system and their uses for the diagnosis and the treatment of proventricular dilatation disease
08/12/2010WO2010011546A3 Pyrrolo [3, 2-b]pyridines and pyrazolo [4, 3 -b] pyridines having 5-ht6 receptor affinity
08/12/2010US20100204332 Method for treating a disease or condition responsive to opening of c1c-2 channel
08/12/2010US20100204324 Optically Active N-(Alpha-Mercaptopropionyl)Glycine
08/12/2010US20100204319 Treatment for benign prostatic hyperplasia
08/12/2010US20100204313 Modulation of nerve pain activity by resiniferatoxin and uses thereof
08/12/2010US20100204294 Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman
08/12/2010US20100204286 Method for reducing gastrointestinal adverse effects of cytotoxic agents
08/12/2010US20100204279 Therapeutic Salt Compositions and Methods
08/12/2010US20100204276 Indole compounds, a process for their preparation and pharmaceutical compositions containing them
08/12/2010US20100204267 Preventive and therapeutic medicament for gastroesophageal reflux disease
08/12/2010US20100204264 Polymorphic form of granisetron base, methods for obtaining it and formulation containing it
08/12/2010US20100204226 Quinazolinones as prolyl hydroxylase inhibitors
08/12/2010US20100204223 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
08/12/2010US20100204222 Pyridopyrimidine derivatives as p13 kinase inhibitors
08/12/2010US20100204214 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/12/2010US20100204212 Fused heterocyclic compounds useful as kinase modulators
08/12/2010US20100204208 Protein kinase c inhibitors and uses thereof
08/12/2010US20100204205 Tolerability of mirtazapine and a second active agent by using them in combination
08/12/2010US20100204188 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
08/12/2010US20100204184 Phosphonates useful as modulators of T-gamma-9-delta-2 activity
08/12/2010US20100204182 Ectonucleotidase inhibitors
08/12/2010US20100204170 Heterobifunctional pan-selectin inhibitors
08/12/2010US20100204156 Use of thymopentin as a therapeutic agent
08/12/2010US20100204152 Use of gluten exorphin c : as a therapeutic agent
08/12/2010US20100204143 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
1 ... 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 ... 1258